A genetically engineered murine model that has conditional expression of an endogenous oncogenic KRAS (G12D) allele in the murine embryo has been established [11], and researchers have used variations of this model to study pancreatic carcinogenesis since this model has the same genetic and phenotypic features of human pancreatic cancer. This evidence concerns the gene KRAS and pancreatic neoplasm.